Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
soft tissue sarcoma
Pharma
FDA signs off on first engineered cell therapy for a solid tumor
Adaptimmune has won FDA approval for its synovial sarcoma treatment Tecelra, the first engineered cell therapy for a solid tumor.
Kevin Dunleavy
Aug 2, 2024 8:56am
Tracon seeks strategic options after injectable PD-L1 drug flop
Jul 2, 2024 4:32pm
Telix buys Lilly's failed cancer drug Lartruvo for $5 million
Apr 11, 2022 11:01am
Lilly eyes current patients amid Lartruvo's global retreat
Apr 25, 2019 11:50am
Lilly's Lartruvo hits a wall as FDA warns against new starts
Jan 25, 2019 10:20am
